Pillstats
Tablet, Film Coated

Losartan Potassium And Hydrochlorothiazide

Hydrochlorothiazide + Losartan Potassium

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers2 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.024$0.047$0.071$0.095Dec 2025Mar 2026Jun 2026
$0.080
Latest avg · Jun 17, 2026
-3%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown7SUPPLYING
ORGANON PHARMA (UK) LIMITEDunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.